Stockreport

Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Entrada Therapeutics, Inc.  (TRDA) 
PDF BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that Dipal Doshi, Chief Executive Officer, will deliver a company p [Read more]